Free. Unsubscribe any time.
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
TEVA PHARMACEUTICAL INDUSTRIES LTD filed 37 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 57 transactions and 2,704,289 shares. 37 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-19, came 14 days after the one before it (2026-08-05) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 18,600 shares, 5,773 more than the 12,827 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 37 filings on file run from 2025-02-19 to 2026-08-19, and state 9 plan adoption dates, from 2024-08-13 to 2026-05-16.
Trades in TEVA PHARMACEUTICAL INDUSTRIES LTD 57
- Francis Richard D — 2025-02-18 · S · 75,506 shares
- Kalif Eliyahu Sharon — 2025-02-28 · S · 55,750 shares
- Daniell Richard — 2025-03-03 · S · 49,314 shares
- Francis Richard D — 2025-03-03 · S · 24,892 shares
- Hughes Eric A — 2025-03-03 · S · 19,726 shares
- Daniell Richard — 2025-03-04 · S · 12,936 shares
- Daniell Richard — 2025-03-04 · S · 21,870 shares
- Daniell Richard — 2025-03-04 · S · 13,353 shares
- Daniell Richard — 2025-03-04 · S · 56,385 shares
- Fox Christine — 2025-03-04 · S · 4,034 shares
- Francis Richard D — 2025-03-04 · S · 6,450 shares
- Francis Richard D — 2025-03-04 · S · 15,514 shares
Adoption dates in TEVA PHARMACEUTICAL INDUSTRIES LTD 9
- 2024-08-13 — stated in 1 filing
- 2024-11-15 — stated in 7 filings
- 2024-11-19 — stated in 3 filings
- 2024-11-29 — stated in 2 filings
- 2025-08-11 — stated in 3 filings
- 2025-11-10 — stated in 12 filings
- 2025-11-14 — stated in 5 filings
- 2025-11-26 — stated in 3 filings
- 2026-05-16 — stated in 1 filing
Results prints in TEVA PHARMACEUTICAL INDUSTRIES LTD 8
- 2025-01-29
- 2025-05-07
- 2025-07-30
- 2025-11-05
- 2026-01-12
- 2026-01-28
- 2026-04-29
- 2026-07-29
Trades before a print in TEVA PHARMACEUTICAL INDUSTRIES LTD 0
- 48 days before the 2025-07-30 print — 2025-06-12 · S · Kalif Eliyahu Sharon · 55,775 shares
- 48 days before the 2026-07-29 print — 2026-06-11 · S · Kalif Eliyahu Sharon · 106,563 shares
- 53 days before the 2026-01-12 print — 2025-11-20 · S · Fox Christine · 28,229 shares
- 54 days before the 2026-07-29 print — 2026-06-05 · S · Francis Richard D · 6,153 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Daniell Richard · 17,295 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Fox Christine · 7,924 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Francis Richard D · 20,025 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Hughes Eric A · 9,533 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Jover Placid · 14,150 shares
- 55 days before the 2026-04-29 print — 2026-03-05 · S · Shields Matthew · 17,295 shares
- 56 days before the 2026-04-29 print — 2026-03-04 · S · Daniell Richard · 33,512 shares
- 56 days before the 2026-04-29 print — 2026-03-04 · S · Daniell Richard · 20,461 shares
Interval to TEVA PHARMACEUTICAL INDUSTRIES LTD’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 48shortest, days
- 3no later print
Adoption dates TEVA PHARMACEUTICAL INDUSTRIES LTD states
- 2024-08-13 in 1 filing
- 2024-11-15 in 7 filings
- 2024-11-19 in 3 filings
- 2024-11-29 in 2 filings
- 2025-08-11 in 3 filings
- 2025-11-10 in 12 filings
- 2025-11-14 in 5 filings
- 2025-11-26 in 3 filings
- 2026-05-16 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on November 15, 2024”
Reported results dates on file
- 2025-01-29
- 2025-05-07
- 2025-07-30
- 2025-11-05
- 2026-01-12
- 2026-01-28
- 2026-04-29
- 2026-07-29
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
- GILEAD SCIENCES, INC. 65
Sources: SEC EDGAR full-text search and the SEC submissions API.